Form 4 for VRDN Viridian Therapeutics, Inc.\DE
Accepted 2021-12-10 00:00:00 ET · period of report 2021-12-08 · accession 0000899243-21-047801 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-10 | 2021-12-08 | VRDN | Violin Jonathan | See Remarks, Dir | C - Cnv Deriv | $0.00 | +627.6K | 630.9K | +18,784% | $0 |
| D | 2021-12-10 | 2021-12-08 | VRDN | Violin Jonathan | See Remarks, Dir | C - Cnv Deriv | $0.00 | -9,413 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-08 | C | A | 627,564 | $0.00 | 630,905 | D | — | — | |
| 2 | Derivative | Series A Non-Voting Convertible Preferred Stock | 2021-12-08 | C | D | 9,413 | $0.00 | 0 | D | — · — to — | 627,564 Common Stock | (F1) Each share of Series A Non-Voting Convertible Preferred Stock is convertible into shares of Common Stock at any time at the option of the holder thereof, into 66.67 shares of Common Stock, subject to certain limitations. |